ComfortDelGro's share price broke out of its consolidation at S$1.72. This indicates that the overall signal has shifted from neutral to bullish and a new upcycle is about to unfold to the next resistance at S$1.81, then S$1.99.
From a fundamental perspective, vaccine rollout across key markets such as Singapore, Australia and UK are on track and the easing of work-from-home (WFH) measures should lift demand for domestic transport. As a result, ComfortDelGro (SGX:C52) is well poised to enjoy positive operating leverage as ridership normalizes.
Potential revision of rail framework could lead to an additional 49% upside to our FY21E EPS forecast by S$0.043 to S$0.013.
Welcome Back!
The government has allowed up to 75% of staff to return to the workplace at any one time from 5 Apr onwards. This is a jump from the current 50%. Concurrently, WFH is no longer the default, as workplaces are now permitted to adopt a more flexible way of working such as staggered start times.
Meanwhile, caps on events are also easing from 24 Apr onwards. For instance, B2B events being piloted can have up to 250 attendees. Those with pre-event testing will be allowed to have up to 750 attendees, in zones of up to 50 attendees each.
Vaccine Rollout Gathers Pace
ComfortDelGro’s key operating countries (Singapore, Australia and the UK) are on track/accelerating the pace of vaccinations.
Singapore has one of the highest local production of AstraZeneca vaccine by CSL.
We expect subsequent easing of movement restrictions and WFH measures. This should lift domestic transport demand, which bodes well for ComfortDelGro.
Technicals Turning Bullish
Our chartist Nik Ihsan Raja Abdullah has the overall trend has shifted from neutral to bullish.
Concurrently, the bullish readings in RSI and DeTrend also suggest that a new upcycle is about to unfold.
ComfortDelGro's share price techncal support at S$1.64, S$1.59.
ComfortDelGro's share price technical resistance at S$1.81 then S$1.99.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....